Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer

Journal of the National Cancer Institute

Volumn 88, Issue 24, 1996, Pages 1834-1839

  Abram, P ^a   A'Hern, R ^a   Baum, M ^a   Berstock, D ^a   Cawthorn, S ^a   Coibion, M ^a   Fennessy, M ^a   Houghton, J ^a   Kissin, M ^a   Lee, D ^a   MacRae, K ^a   Moritz, S ^a   Odling Smee, W ^a   Perry, M ^a   Riley, D ^a   Saunders, C ^a   Sauven, P ^a   Smith, I ^a   Tobias, J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; RISK BENEFIT ANALYSIS;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; LIFE TABLES; MIDDLE AGED; RISK; SURVIVAL ANALYSIS; TAMOXIFEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 8044243594     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.24.1834     Document Type: Article

References (0)